Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. iran
  4. immune activation
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • Asia & Middle East
  • Iran
Brands

  • selleck chemicals
  • systimmune
  • pure biologics
  • galvanize aliya
  • sumitomo
View all brands

Immune Activation Equipment & Supplies In Iran

41 equipment items found
Available In IranNear Iran

Selleck Chemicals - Model A2461 - Sifalimumab (Anti-IFNa1)

Selleck Chemicals - Model A2461 - Sifalimumab (Anti-IFNa1)

Manufactured by:Selleck Chemicals LLC   based in, NORTH AMERICA
Sifalimumab (Anti-IFNa1) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. MW: 145.5 ...
CONTACT SUPPLIER

Selleck Chemicals - Model A2390 - Tesnatilimab (Anti-NKG2D / CD314)

Selleck Chemicals - Model A2390 - Tesnatilimab (Anti-NKG2D / CD314)

Manufactured by:Selleck Chemicals LLC   based in, NORTH AMERICA
Tesnatilimab (Anti-NKG2D / CD314) is a recombinant human immunoglobulin G4 (IgG4) monoclonal antibody against the immune activating receptor natural-killer group 2, member D receptor protein (NKG2D or KLRK1), with potential immunomodulating and anti-inflammatory activities. MW: 146.5 ...
CONTACT SUPPLIER

Model OGB23501 - Tri-Specific Tumor Microenvironment (TME)

Model OGB23501 - Tri-Specific Tumor Microenvironment (TME)

by:Onegene Biotechnology   based inSuwon, SOUTH KOREA
OGB23501 is a first-in-class tri-specific tumor microenvironment (TME) immune activator, which simultaneously targets PD-1, CTLA-4, and VEGF. We aim to develop it as a potential backbone therapy for melanoma, NSCLC, HCC, and renal ...
CONTACT SUPPLIER

Selleck Chemicals - Model A2597 - Alsevalimab (Anti-B7-H4 / VTCN1)

Selleck Chemicals - Model A2597 - Alsevalimab (Anti-B7-H4 / VTCN1)

Manufactured by:Selleck Chemicals LLC   based in, NORTH AMERICA
Alsevalimab (Anti-B7-H4 / VTCN1) is a human monoclonal antibody targeting B7-H4. It has potential antineoplastic and immune checkpoint inhibitory activities. MW :144.74 ...
CONTACT SUPPLIER

Off-the-Shelf Natural Killer (NK) Cells for Oncology

Off-the-Shelf Natural Killer (NK) Cells for Oncology

Manufactured by:Senti Biosciences   based inSouth San Francisco, CALIFORNIA (USA)
Natural Killer (NK) cells are essential components of the immune system, playing an important role in the body’s defensive response against tumors and infected cells. NK cells constantly patrol the body to detect and neutralize foreign cells. Senti Bio believes there are several advantages that NK cells confer in relation to other potential immune cell ...
CONTACT SUPPLIER

Selleck Chemicals - Model A2133 - Anti-mouse LAG-3-InVivo

Selleck Chemicals - Model A2133 - Anti-mouse LAG-3-InVivo

Manufactured by:Selleck Chemicals LLC   based in, NORTH AMERICA
Anti-mouse LAG-3-InVivo (Clone: C9B7W) monoclonal antibody reacts with mouse LAG-3 also known as CD223. LAG-3 promotes immune responses by activating antigen-presenting cells. The C9B7W antibody has been reported to block the function of murine LAG-3 in vivo and in ...
CONTACT SUPPLIER

Model STING-Agonist - Immunosynthen

Model STING-Agonist - Immunosynthen

Manufactured by:Mersana Therapeutics   based inCambridge, MASSACHUSETTS (USA)
Immunosynthen is our novel immunostimulatory ADC platform designed to take ADCs beyond traditional cytotoxic drugs to targeted stimulation of the innate immune system. Through the safe and efficient delivery of a novel immunomodulatory STING agonist, ADCs created with our Immunosynthen platform have the potential to address the challenges of efficacy, delivery and tolerability. ...
CONTACT SUPPLIER

Selleck Chemicals - Model A2832 - Domvanalimab (Anti-TIGIT)

Selleck Chemicals - Model A2832 - Domvanalimab (Anti-TIGIT)

Manufactured by:Selleck Chemicals LLC   based in, NORTH AMERICA
Domvanalimab (Anti-TIGIT) is a humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT) with potential immune checkpoint inhibitory activity. MW : 145.12 ...
CONTACT SUPPLIER

Model ES014 - Anti-CD39xTGF-ß BsAb Dual-Acting Molecule

Model ES014 - Anti-CD39xTGF-ß BsAb Dual-Acting Molecule

Manufactured by:Elpiscience   based inShanghai, CHINA
ES014 is a first-in-class anti-CD39xTGF-β bispecific antibody (bsAb) that simultaneously targets the adenosine and TGF-β pathways, two major immunosuppressive mechanisms in the tumor microenvironment (TME). Solid tumors frequently express TGF-β, which suppresses T cell activation and induces CD39 expression, the rate-limiting enzyme in the ATP-adenosine pathway. ...
CONTACT SUPPLIER

Sumitomo - Immunotherapeutic Cancer Vaccines

Sumitomo - Immunotherapeutic Cancer Vaccines

by:Sumitomo Pharma Oncology, Inc.   based inCambridge, MASSACHUSETTS (USA)
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to drive sufficient tumor immunogenicity, leading to poor clinical responses.1 The reason for this may be that previous ...
CONTACT SUPPLIER

Selleck Chemicals - Model A2327 - Ragifilimab (Anti-TNFRSF18 / GITR / CD357)

Selleck Chemicals - Model A2327 - Ragifilimab (Anti-TNFRSF18 / GITR / CD357)

Manufactured by:Selleck Chemicals LLC   based in, NORTH AMERICA
Ragifilimab (Anti-TNFRSF18 / GITR / CD357) is an anti-human glucocorticoid-induced tumor necrosis factor receptor (tumor necrosis factor superfamily, member 18; TNFRSF18; GITR; CD357) agonistic humanized monoclonal antibody with potential immune checkpoint modulating activity. MW : 145.5 ...
CONTACT SUPPLIER

Cancer Vaccines

Cancer Vaccines

Manufactured by:Virometix AG   based inSchlieren, SWITZERLAND
Effective antigen delivery and a strong and durable response is the basis for successful cancer vaccines. The SVLP approach, with its modular and flexible design, the inherent adjuvant properties and other immune system activators, lends itself to the development of particle-based vaccines against cancer: SVLPs displaying cancer antigens are optimally presented ...
CONTACT SUPPLIER

Sumitomo - Model DSP-0509 - TLR7 Agonist

Sumitomo - Model DSP-0509 - TLR7 Agonist

by:Sumitomo Pharma Oncology, Inc.   based inCambridge, MASSACHUSETTS (USA)
DSP-0509 is an investigational Toll-like receptor (TLR) 7 agonist, which is hypothesized to induce cytokine production, activate cytotoxic T lymphocytes, and sustain immune-mediated antitumor ...
CONTACT SUPPLIER

SystImmune - Model SI-B003 - Tetravalent

SystImmune - Model SI-B003 - Tetravalent

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
By combining bi-valency with bi-specificity in the tetravalent format, the dual checkpoint molecule utilizes avidity and bi-specificity to improve anti-cancer immune cell function. The specificity enhancement both synergistically enhance and expand the breadth of immune cell activity that is diminished in cancer patients (SEBA). The ...
CONTACT SUPPLIER

Novavax - Model GP - Glycoprotein Vaccine

Novavax - Model GP - Glycoprotein Vaccine

Manufactured by:Novavax   based inGaithersburg, MARYLAND (USA)
In 5 separate studies, carried out in collaboration with the National Institute of Allergy and Infectious Diseases, active immunization with the Ebola GP vaccine was shown to be highly immunogenic and efficacious in preventing lethal disease in non-human primates challenged with EBOV. Our 2015 Phase 1 clinical trial demonstrated that our Ebola GP vaccine is ...
CONTACT SUPPLIER

SystImmune - Model GNC-038 - Guidance and Navigation Control (GNC) Molecules

SystImmune - Model GNC-038 - Guidance and Navigation Control (GNC) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC molecule is multi-function. In the process of killing, the GNC is designed to educate and empower the ...
CONTACT SUPPLIER

SystImmune - Model GNC-035 - Guidance and Navigation Control (GNC) Molecules

SystImmune - Model GNC-035 - Guidance and Navigation Control (GNC) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC molecule is multi-function. In the process of killing, the GNC is designed to educate and empower the ...
CONTACT SUPPLIER

SystImmune - Model GNC-039 - Guidance and Navigation Control (GNC) Molecules

SystImmune - Model GNC-039 - Guidance and Navigation Control (GNC) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC molecule is multi-function. In the process of killing, the GNC is designed to educate and empower the ...
CONTACT SUPPLIER

Q-Plex - Model Interleukin 4 (IL-4) - Rat Analytes

Q-Plex - Model Interleukin 4 (IL-4) - Rat Analytes

Manufactured by:Quansys Biosciences Inc.    based inLogan, UTAH (USA)
Interleukin 4 (IL-4) is a cytokine that has pleiotropic effects during active immune responses. Its primary role is to induce differentiation of helper T-cells and active B cells. IL-4’s other roles include regulating immunity, upregulating MHC class II production, supporting the proliferation of epithelial cells, and ...
CONTACT SUPPLIER

Nobilis - Model IB - Comprehensive Line Vaccines

Nobilis - Model IB - Comprehensive Line Vaccines

Manufactured by:Merck Animal Health   based inRahway, NEW JERSEY (USA)
NOBILIS IB VACCINES: Comprehensive line of vaccines for active immunization of poultry against disease caused by the Infectious Bronchitis virus. The NOBILIS IB family contains vaccines for protection against several serotypes, like (but not limited to) serotypes 4/91, Massachusetts Ma5, or related types. ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT